Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry
Abstract Background Military individuals, retirees, and their families have free care or minimal out‐of‐pocket costs in the US military health system (MHS). In contrast, out‐of‐pocket costs in the US general population vary substantially. This study compared cancer patients with various insurance ty...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-11-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.6655 |
| _version_ | 1797398912078708736 |
|---|---|
| author | James T. Flanary Jie Lin Craig D. Shriver Kangmin Zhu |
| author_facet | James T. Flanary Jie Lin Craig D. Shriver Kangmin Zhu |
| author_sort | James T. Flanary |
| collection | DOAJ |
| description | Abstract Background Military individuals, retirees, and their families have free care or minimal out‐of‐pocket costs in the US military health system (MHS). In contrast, out‐of‐pocket costs in the US general population vary substantially. This study compared cancer patients with various insurance types in the general population to those in the MHS in cancer stage at diagnosis. Methods Patients were identified from the US Department of Defense's (DoD) Automated Central Tumor Registry (ACTUR) and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. Tumor stage at diagnosis of breast, prostate, lung, and colon cancers during 2007–2013 was compared between ACTUR and SEER insurance categories of “insured,” “insured‐no specifics,” “any Medicaid,” and “uninsured,” A multivariable logistic regression analysis estimated the odds ratio (OR) of late stage (Stages III and IV) versus early stage (Stages I and II) cancers comparing SEER insurance status to ACTUR. Results There were 18,440 eligible patients identified from ACTUR and 831,959 patients identified from SEER. For all cancer types, patients in the SEER‐insured/no specifics, Medicaid, and uninsured groups had significantly greater likelihood of late stage diagnosis compared to ACTUR patients. The adjusted ORs were greatest among uninsured and Medicaid patients. The SEER‐insured group also had a significantly higher odds of advanced stage disease than ACTUR patients for prostate cancer and lung cancer. Conclusion Patients in the MHS with universal access to healthcare were diagnosed at an earlier stage than those in the general population. This difference was most evident compared to Medicaid and uninsured groups. |
| first_indexed | 2024-03-09T01:32:22Z |
| format | Article |
| id | doaj.art-89d746a73c574678922c5c5d0a405f93 |
| institution | Directory Open Access Journal |
| issn | 2045-7634 |
| language | English |
| last_indexed | 2024-03-09T01:32:22Z |
| publishDate | 2023-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj.art-89d746a73c574678922c5c5d0a405f932023-12-09T07:52:06ZengWileyCancer Medicine2045-76342023-11-011222209892100010.1002/cam4.6655Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer RegistryJames T. Flanary0Jie Lin1Craig D. Shriver2Kangmin Zhu3Department of Surgery Walter Reed National Military Medical Center Bethesda Maryland USADepartment of Surgery, Murtha Cancer Center Research Program Uniformed Services University of the Health Sciences Bethesda Maryland USADepartment of Surgery Walter Reed National Military Medical Center Bethesda Maryland USADepartment of Surgery, Murtha Cancer Center Research Program Uniformed Services University of the Health Sciences Bethesda Maryland USAAbstract Background Military individuals, retirees, and their families have free care or minimal out‐of‐pocket costs in the US military health system (MHS). In contrast, out‐of‐pocket costs in the US general population vary substantially. This study compared cancer patients with various insurance types in the general population to those in the MHS in cancer stage at diagnosis. Methods Patients were identified from the US Department of Defense's (DoD) Automated Central Tumor Registry (ACTUR) and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. Tumor stage at diagnosis of breast, prostate, lung, and colon cancers during 2007–2013 was compared between ACTUR and SEER insurance categories of “insured,” “insured‐no specifics,” “any Medicaid,” and “uninsured,” A multivariable logistic regression analysis estimated the odds ratio (OR) of late stage (Stages III and IV) versus early stage (Stages I and II) cancers comparing SEER insurance status to ACTUR. Results There were 18,440 eligible patients identified from ACTUR and 831,959 patients identified from SEER. For all cancer types, patients in the SEER‐insured/no specifics, Medicaid, and uninsured groups had significantly greater likelihood of late stage diagnosis compared to ACTUR patients. The adjusted ORs were greatest among uninsured and Medicaid patients. The SEER‐insured group also had a significantly higher odds of advanced stage disease than ACTUR patients for prostate cancer and lung cancer. Conclusion Patients in the MHS with universal access to healthcare were diagnosed at an earlier stage than those in the general population. This difference was most evident compared to Medicaid and uninsured groups.https://doi.org/10.1002/cam4.6655early detection of cancermilitary personnel/statistics and numerical dataneoplasm stagingSEER programUnited States/epidemiology |
| spellingShingle | James T. Flanary Jie Lin Craig D. Shriver Kangmin Zhu Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry Cancer Medicine early detection of cancer military personnel/statistics and numerical data neoplasm staging SEER program United States/epidemiology |
| title | Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry |
| title_full | Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry |
| title_fullStr | Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry |
| title_full_unstemmed | Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry |
| title_short | Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry |
| title_sort | cancer stage at diagnosis comparison of insurance status in seer to the department of defense cancer registry |
| topic | early detection of cancer military personnel/statistics and numerical data neoplasm staging SEER program United States/epidemiology |
| url | https://doi.org/10.1002/cam4.6655 |
| work_keys_str_mv | AT jamestflanary cancerstageatdiagnosiscomparisonofinsurancestatusinseertothedepartmentofdefensecancerregistry AT jielin cancerstageatdiagnosiscomparisonofinsurancestatusinseertothedepartmentofdefensecancerregistry AT craigdshriver cancerstageatdiagnosiscomparisonofinsurancestatusinseertothedepartmentofdefensecancerregistry AT kangminzhu cancerstageatdiagnosiscomparisonofinsurancestatusinseertothedepartmentofdefensecancerregistry |